Table 2.

Cytotoxicity (IC₅₀, μM) of compounds 1–3 against MDA-MB-435, HepG2, and HCT-116 cell lines ^a.

Samples	Cell lines
	MDA-MB-435 c	HepG2 c	HCT-116 c
1	8.56 ± 0.81	35.32 ± 1.67	7.82 ± 1.02
2	7.68 ± 0.90	32.70 ± 1.50	6.93 ± 0.63
3	16.49 ± 0.78	41.86 ± 0.57	18.63 ± 0.95
Resveratrol b	68.56 ± 1.36	43.52 ± 1.29	38.87 ± 1.58
Epirubicin b	0.56 ± 0.06	0.96 ± 0.02	0.48 ± 0.03

^a IC₅₀ values are taken as means ± standard deviation from three independent experiment; ^b Used as a positive control. MDA-MB-435 ^c human breast cancer cell line; HepG2 ^c human liver cancer cell line; HCT-116 ^c, human colon cancer cell line.